Mohan Yadav Holds Key Talks With Sun Pharma Chief, ₹3,000 Crore Investment And 1,750 Jobs In Focus

Mohan Yadav, the Chief Minister of Madhya Pradesh, engaged in crucial discussions with Dilip Shanghvi, the Chairman of Sun Pharmaceutical Industries, in Mumbai. The meeting aimed to explore potential investments and expansion plans for Sun Pharma in the region. A significant focus of the talks was the proposed Rs 3,000 crore greenfield pharmaceutical manufacturing facility in Pithampur, which is expected to create over 1,750 jobs, including approximately 1,250 direct positions and 500 indirect roles.

The facility, set to be established in Sector 7 of Pithampur, will manufacture pharmaceutical formulations for markets in India, the United States, Europe, and beyond. During the meeting, CM Yadav directed officials to expedite land acquisition, address local administrative challenges, and ensure the availability of essential infrastructure such as water, electricity, and road connectivity by December 2026.

Sun Pharma's long-term energy strategy was another key area of discussion. The company seeks government support in identifying suitable land for a substantial solar power project, reflecting the industry's commitment to sustainable practices. Additionally, discussions encompassed faster approvals, infrastructure support, and incentives to facilitate the renewable energy facility's development.

The proposed Pithampur project builds upon Sun Pharma's existing presence in Madhya Pradesh, where the company operates manufacturing and formulation facilities, currently employing around 3,958 people. CM Yadav emphasized the state's dedication to offering investor-friendly policies, expediting clearances, and providing essential infrastructure to attract significant industrial investments.

The meeting underscored the collaborative approach between the government and the private sector in driving economic growth and job creation in the region.